BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,617 | -12.2% | 201,819 | +6.0% | 0.04% | -6.5% |
Q2 2023 | $8,673 | +32.3% | 190,363 | +17.7% | 0.05% | +21.1% |
Q1 2023 | $6,558 | -18.2% | 161,687 | +2.8% | 0.04% | -24.0% |
Q4 2022 | $8,014 | -99.9% | 157,237 | 0.0% | 0.05% | -12.3% |
Q3 2022 | $8,469,000 | -33.6% | 157,237 | -20.8% | 0.06% | -31.3% |
Q2 2022 | $12,756,000 | +6.9% | 198,599 | +29.1% | 0.08% | +25.8% |
Q1 2022 | $11,929,000 | -12.9% | 153,843 | -3.5% | 0.07% | -1.5% |
Q4 2021 | $13,690,000 | +3.5% | 159,478 | -3.0% | 0.07% | -2.9% |
Q3 2021 | $13,221,000 | -57.7% | 164,376 | -57.6% | 0.07% | -57.7% |
Q2 2021 | $31,221,000 | +3.7% | 387,839 | +8.6% | 0.16% | -4.7% |
Q1 2021 | $30,121,000 | -51.7% | 357,138 | -54.0% | 0.17% | -54.9% |
Q4 2020 | $62,332,000 | -15.3% | 776,820 | -15.1% | 0.38% | -29.7% |
Q3 2020 | $73,570,000 | -50.7% | 914,820 | -47.2% | 0.54% | -15.0% |
Q2 2020 | $149,266,000 | +81.9% | 1,733,640 | +71.6% | 0.63% | -64.1% |
Q1 2020 | $82,042,000 | +201.9% | 1,010,500 | +210.9% | 1.77% | +275.7% |
Q4 2019 | $27,176,000 | +88.0% | 325,000 | +82.8% | 0.47% | +67.9% |
Q1 2019 | $14,457,000 | +34.9% | 177,800 | +9.2% | 0.28% | +29.6% |
Q4 2018 | $10,715,000 | -14.6% | 162,800 | 0.0% | 0.22% | +40.3% |
Q3 2018 | $12,550,000 | +20.7% | 162,800 | +15.6% | 0.15% | -24.5% |
Q2 2018 | $10,397,000 | +12.9% | 140,800 | -0.6% | 0.20% | +112.5% |
Q1 2018 | $9,210,000 | -17.0% | 141,600 | -17.5% | 0.10% | -27.3% |
Q4 2017 | $11,092,000 | -15.0% | 171,600 | -17.5% | 0.13% | -19.5% |
Q3 2017 | $13,052,000 | +107.3% | 208,000 | +100.0% | 0.16% | +1.9% |
Q2 2017 | $6,296,000 | +30.5% | 104,000 | +11.8% | 0.16% | +20.1% |
Q1 2017 | $4,823,000 | +89.7% | 93,000 | +39.5% | 0.13% | +173.5% |
Q4 2015 | $2,543,000 | – | 66,653 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |